| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $66.0M | -12.4% |
| Cost of Revenue | $144.2M | +42.7% |
| Gross Profit | -$78.2M | -204.5% |
| R&D Expense | $137.6M | -40.6% |
| SG&A Expense | $26.0M | -77.6% |
| Operating Income | -$296.8M | +31.8% |
| Pre-tax Income | -$366.0M | -33.6% |
| Income Tax | $338K | +145.5% |
| Net Income | -$366.3M | -34.1% |
| EPS (Basic) | -$6.33 | +27.2% |
| EPS (Diluted) | -$6.33 | +27.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.3M | -75.5% |
| Accounts Receivable | $6.0M | -58.2% |
| Inventory | $6.7M | -55.4% |
| Current Assets | $56.9M | -76.8% |
| Total Assets | $131.3M | -64.0% |
| Current Liabilities | $137.1M | +126.3% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$196.5M | +29.0% |
| Capital Expenditures | $2.0M | -60.3% |
| Investing Cash Flow | $96.8M | +128.0% |
| Financing Cash Flow | $36.6M | -79.5% |
| Free Cash Flow | -$198.5M | +29.5% |
| $608.3M |
| +3.8% |
| Stockholders' Equity | -$477.0M | -116.0% |